Metabolomic biomarkers for (R, S)-ketamine and (S)-ketamine in treatment-resistant depression and healthy controls: A systematic review.
Rakesh KumarNicolas A NunezNeha S JoshiBoney JosephAlessandra VerdeAshok SeshadriAlfredo B Cuellar BarbozaLarry J ProkopGustavo C MedeirosBalwinder SinghPublished in: Bipolar disorders (2024)
This systematic review provides preliminary evidence that ketamine may cause changes in several important pathways involved in energy metabolism and inflammation. Larger and more rigorous studies are needed.